Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Gibson

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Chemical Science|May 22, 2018
Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistanceEmanuele Petruzzella, Roman Sirota, Irene Solazzo, et al.
Chemical Communications (Cambridge, England)|November 30, 2011
Pt(IV) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbateJenny Z Zhang, Ezequiel Wexselblatt, Trevor W Hambley, et al.
Journal of Medicinal Chemistry|November 15, 2002
Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell linesYousef Najajreh, Jose Manuel Perez, Carmen Navarro-Ranninger, et al.
Dalton Transactions (Cambridge, England : 2003)|November 20, 2014
The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactionsViktor Brabec, Jitka Pracharova, Olga Novakova, et al.
Biochemistry|May 21, 2003
DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell linesJana Kasparkova, Victoria Marini, Yousef Najajreh, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 12, 2019
An Anticancer Pt<sup>IV</sup> Prodrug That Acts by Mechanisms Involving DNA Damage and Different Epigenetic EffectsHana Kostrhunova, Emanuele Petruzzella, Dan Gibson, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|October 7, 2005
Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligandYousef Najajreh, Jana Kasparkova, Victoria Marini, et al.
Journal of Assisted Reproduction and Genetics|May 3, 2014
Zygote serine decreased uptake from the fertilization medium is associated with implantation and pregnancyEinat Zivi, Dinorah Barash, Einat Aizenman, et al.
Angewandte Chemie (International Ed. in English)|February 5, 2020
A Multi-action and Multi-target Ru<sup>II</sup> -Pt<sup>IV</sup> Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant CancersJohannes Karges, Thirumal Yempala, Mickaël Tharaud, et al.
Inorganic Chemistry|December 3, 2019
Synthesis and Cytotoxicity of Water-Soluble Dual- and Triple-Action Satraplatin Derivatives: Replacement of Equatorial Chlorides of Satraplatin by AcetatesSubhendu Karmakar, Isabella Poetsch, Christian R Kowol, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Chemical Science|May 22, 2018
Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistanceEmanuele Petruzzella, Roman Sirota, Irene Solazzo, et al.
Chemical Communications (Cambridge, England)|November 30, 2011
Pt(IV) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbateJenny Z Zhang, Ezequiel Wexselblatt, Trevor W Hambley, et al.
Journal of Medicinal Chemistry|November 15, 2002
Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell linesYousef Najajreh, Jose Manuel Perez, Carmen Navarro-Ranninger, et al.
Dalton Transactions (Cambridge, England : 2003)|November 20, 2014
The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactionsViktor Brabec, Jitka Pracharova, Olga Novakova, et al.
Biochemistry|May 21, 2003
DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell linesJana Kasparkova, Victoria Marini, Yousef Najajreh, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 12, 2019
An Anticancer Pt<sup>IV</sup> Prodrug That Acts by Mechanisms Involving DNA Damage and Different Epigenetic EffectsHana Kostrhunova, Emanuele Petruzzella, Dan Gibson, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|October 7, 2005
Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligandYousef Najajreh, Jana Kasparkova, Victoria Marini, et al.
Journal of Assisted Reproduction and Genetics|May 3, 2014
Zygote serine decreased uptake from the fertilization medium is associated with implantation and pregnancyEinat Zivi, Dinorah Barash, Einat Aizenman, et al.
Angewandte Chemie (International Ed. in English)|February 5, 2020
A Multi-action and Multi-target Ru<sup>II</sup> -Pt<sup>IV</sup> Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant CancersJohannes Karges, Thirumal Yempala, Mickaël Tharaud, et al.
Inorganic Chemistry|December 3, 2019
Synthesis and Cytotoxicity of Water-Soluble Dual- and Triple-Action Satraplatin Derivatives: Replacement of Equatorial Chlorides of Satraplatin by AcetatesSubhendu Karmakar, Isabella Poetsch, Christian R Kowol, et al.
Pageof 9